Published in Infect Immun on May 01, 1987
Pathogenesis of group A streptococcal infections. Clin Microbiol Rev (2000) 15.35
IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J (2002) 2.77
C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun (1996) 2.77
Identification of a divergent M protein gene and an M protein-related gene family in Streptococcus pyogenes serotype 49. J Bacteriol (1989) 2.04
SclA, a novel collagen-like surface protein of Streptococcus pyogenes. Infect Immun (2000) 1.82
Molecular epidemiologic analysis of the type A streptococcal exotoxin (erythrogenic toxin) gene (speA) in clinical Streptococcus pyogenes strains. Infect Immun (1989) 1.76
M1 protein and protein H: IgGFc- and albumin-binding streptococcal surface proteins encoded by adjacent genes. Biochem J (1994) 1.55
Protein D, an immunoglobulin D-binding protein of Haemophilus influenzae: cloning, nucleotide sequence, and expression in Escherichia coli. Infect Immun (1991) 1.25
Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class. J Bacteriol (1992) 1.22
Analysis of genes encoding two unique type IIa immunoglobulin G-binding proteins expressed by a single group A streptococcal isolate. Infect Immun (1994) 1.20
Binding of IgA and/or IgG is a common property among clinical isolates of group A streptococci. Epidemiol Infect (1990) 1.09
Functional and serological analysis of type II immunoglobulin G-binding proteins expressed by pathogenic group A streptococci. J Clin Microbiol (1992) 1.08
M12 protein from Streptococcus pyogenes is a receptor for immunoglobulin G3 and human albumin. Infect Immun (1994) 1.02
Non-immune binding of human IgG to M-related proteins confers resistance to phagocytosis of group A streptococci in blood. PLoS One (2013) 0.87
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A (1979) 365.71
The pUC plasmids, an M13mp7-derived system for insertion mutagenesis and sequencing with synthetic universal primers. Gene (1982) 102.30
A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem (1977) 36.95
THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HAEMOLYTICUS : I. DEMONSTRATION OF A TYPE-SPECIFIC SUBSTANCE IN EXTRACTS OF STREPTOCOCCUS HAEMOLYTICUS. J Exp Med (1928) 17.15
Colony hybridization. Methods Enzymol (1979) 4.47
Streptococcal M6 protein expressed in Escherichia coli. Localization, purification, and comparison with streptococcal-derived M protein. J Exp Med (1984) 3.69
A surface component in group A, C, and G streptococci with non-immune reactivity for immunoglobulin G. J Immunol (1973) 3.23
M proteins of group A streptococci. Bacteriol Rev (1974) 3.15
Structure of the IgG-binding regions of streptococcal protein G. EMBO J (1986) 2.20
Heterogeneity of nonimmune immunoglobulin Fc reactivity among gram-positive cocci: description of three major types of receptors for human immunoglobulin G. Infect Immun (1977) 2.15
Small DNA deletions creating avirulence in Streptococcus pyogenes. Science (1984) 1.92
A DNA substitution in the group A streptococcal bacteriophage SP24. Virology (1983) 1.34
Bacteriophage control of antiphagocytic determinants in group A streptococci. J Exp Med (1980) 1.25
Isolation and some properties of an IgG Fc-binding protein from group A streptococci type 15. Int Arch Allergy Appl Immunol (1982) 1.08
Interaction of streptococci with the Fc fragment of IgG. Acta Pathol Microbiol Scand C (1976) 1.02
Identification of a unique receptor on a group A streptococcus for the Fc region of human IgG3. J Immunol (1986) 0.98
Electron microscopic study of the location of the Fc-reacting factor on group A streptococci. Microbios (1982) 0.87
Identification of distinct Fc-receptor molecules on streptococci and staphylococci. J Clin Lab Immunol (1984) 0.84
Demonstration of the non-identity between the Fc receptor for human IgG from group A streptococci type 15 and M protein, peptidoglycan and the group specific carbohydrate. Acta Pathol Microbiol Scand C (1979) 0.81
C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun (1996) 2.77
Streptococcus pyogenes type 12 M protein gene regulation by upstream sequences. J Bacteriol (1987) 2.54
Group A streptococci efficiently invade human respiratory epithelial cells. Proc Natl Acad Sci U S A (1994) 2.39
Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A (1985) 2.38
Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J Biol Chem (1990) 2.31
Restricted deposition of C3 on M+ group A streptococci: correlation with resistance to phagocytosis. J Immunol (1982) 2.27
Physical characterization of ten R plasmids obtained from an outbreak of nosocomial Klebsiella pneumoniae infections. Antimicrob Agents Chemother (1979) 2.21
Coregulation of type 12 M protein and streptococcal C5a peptidase genes in group A streptococci: evidence for a virulence regulon controlled by the virR locus. J Bacteriol (1990) 2.16
Insertional inactivation of streptolysin S expression in Streptococcus pyogenes. J Bacteriol (1983) 2.13
Nosocomial multiply resistant Klebsiella pneumoniae: epidemiology of an outbreak of apparent index case origin. Antimicrob Agents Chemother (1979) 2.13
Epidemiology of group-B streptococcal carriage in pregnant women and newborn infants. J Med Microbiol (1977) 2.12
Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge. Infect Immun (1996) 2.09
Identification of a divergent M protein gene and an M protein-related gene family in Streptococcus pyogenes serotype 49. J Bacteriol (1989) 2.04
Three-dimensional volume rendering of spiral CT data: theory and method. Radiographics (1999) 2.00
DNA fingerprinting of Streptococcus zooepidemicus (Lancefield group C) as an aid to epidemiological study. J Infect Dis (1987) 1.99
Fc-receptor and M-protein genes of group A streptococci are products of gene duplication. Proc Natl Acad Sci U S A (1989) 1.97
Inhibition of alternative complement pathway opsonization by group A streptococcal M protein. J Infect Dis (1979) 1.97
In vivo Streptococcus pyogenes C5a peptidase activity: analysis using transposon- and nitrosoguanidine-induced mutants. J Infect Dis (1987) 1.88
Group B streptococci inhibit the chemotactic activity of the fifth component of complement. J Immunol (1988) 1.83
Group A streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s. J Infect Dis (1989) 1.75
Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells. Infect Immun (1998) 1.70
Human neutrophil chemotactic response to group A streptococci: bacteria-mediated interference with complement-derived chemotactic factors. Infect Immun (1983) 1.70
Relationship between virulence and immunity as revealed in recent studies of the F1 capsule of Yersinia pestis. Clin Infect Dis (1995) 1.69
Nucleotide substitutions and small-scale insertion produce size and antigenic variation in group A streptococcal M1 protein. Mol Microbiol (1993) 1.66
Expression of M type 12 protein by a group A streptococcus exhibits phaselike variation: evidence for coregulation of colony opacity determinants and M protein. Infect Immun (1987) 1.66
Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol (1990) 1.60
Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A Streptococcus. Infect Immun (1997) 1.60
Deletion and complementation analysis of biotin gene cluster of Escherichia coli. J Bacteriol (1972) 1.57
Characterization of prototype and clinically defined strains of Streptococcus suis by genomic fingerprinting. J Clin Microbiol (1990) 1.56
Location of promoter and operator sites in the biotin gene cluster of Escherichia coli. Proc Natl Acad Sci U S A (1972) 1.55
Lung transplantation for cystic fibrosis patients with Burkholderia cepacia complex. Survival linked to genomovar type. Am J Respir Crit Care Med (2001) 1.52
Conservation of the C5a peptidase genes in group A and B streptococci. Infect Immun (1996) 1.51
Evidence for group A-related M protein genes in human but not animal-associated group G streptococcal pathogens. Microb Pathog (1987) 1.51
Short- and long-term efficacy of single-dose subunit vaccines against Yersinia pestis in mice. Am J Trop Med Hyg (1998) 1.49
High-frequency intracellular invasion of epithelial cells by serotype M1 group A streptococci: M1 protein-mediated invasion and cytoskeletal rearrangements. Mol Microbiol (1999) 1.48
Automatic liver segmentation technique for three-dimensional visualization of CT data. Radiology (1996) 1.44
Genetic instability of M protein and serum opacity factor of group A streptocci: evidence suggesting extrachromosomal control. Infect Immun (1975) 1.44
VirR and Mry are homologous trans-acting regulators of M protein and C5a peptidase expression in group A streptococci. Mol Gen Genet (1993) 1.39
Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors. J Immunol (1985) 1.37
Identification of epidemic strains of Streptococcus suis by genomic fingerprinting. J Clin Microbiol (1991) 1.36
A DNA substitution in the group A streptococcal bacteriophage SP24. Virology (1983) 1.34
Severe invasive group A streptococcal disease: clinical description and mechanisms of pathogenesis. J Lab Clin Med (1996) 1.34
Skeletal 3-D CT: advantages of volume rendering over surface rendering. Skeletal Radiol (1996) 1.32
Degenerate oligonucleotide primers for enzymatic amplification of recA sequences from gram-positive bacteria and mycoplasmas. J Bacteriol (1992) 1.32
Evidence consistent with horizontal transfer of the gene (emm12) encoding serotype M12 protein between group A and group G pathogenic streptococci. Infect Immun (1992) 1.32
Bacteriophage control of antiphagocytic determinants in group A streptococci. J Exp Med (1980) 1.25
Plasmid macroevolution in a nosocomial environment: demonstration of a persistent molecular polymorphism and construction of a cladistic phylogeny on the basis of restriction data. Mol Gen Genet (1984) 1.24
Architecture of the vir regulons of group A streptococci parallels opacity factor phenotype and M protein class. J Bacteriol (1992) 1.22
Evaluation of a new generation of culture bottle using an automated bacterial culture system for detecting nine common contaminating organisms found in platelet components. Transfusion (2002) 1.22
Purification and characteristics of the streptococcal chemotactic factor inactivator. Infect Immun (1985) 1.22
Insertional inactivation of virR in Streptococcus pyogenes M49 demonstrates that VirR functions as a positive regulator of ScpA, FcRA, OF, and M protein. FEMS Microbiol Lett (1995) 1.18
Purification of the proteinase from group B streptococci that inactivates human C5a. Biochim Biophys Acta (1991) 1.17
Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis (1998) 1.16
Localization of the streptococcal C5a peptidase to the surface of group A streptococci. Infect Immun (1986) 1.15
Cloning and expression of the streptococcal C5a peptidase gene in Escherichia coli: linkage to the type 12 M protein gene. Infect Immun (1989) 1.15
Sequence and type-specific immunogenicity of the amino-terminal region of type 1 streptococcal M protein. J Immunol (1987) 1.13
Hospital distribution, persistence, and reintroduction of related gentamicin R plasmids. Antimicrob Agents Chemother (1986) 1.13
Type M12 protein from Streptococcus pyogenes is a receptor for IgG3. J Immunol (1993) 1.11
Possible dual function of M protein: resistance to bacteriophage A25 and resistance to phagocytosis by human leukocytes. Infect Immun (1977) 1.08
Immune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice. Infect Immun (1999) 1.08
Dual-phase spiral CT angiography with volumetric 3D rendering for preoperative liver transplant evaluation: preliminary observations. J Comput Assist Tomogr (1998) 1.07
Genetic dissection of the Streptococcus pyogenes M1 protein: regions involved in fibronectin binding and intracellular invasion. Microb Pathog (2001) 1.07
A nonpeptide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin alpha 5beta 1-fibronectin-M1 protein complexes. Proc Natl Acad Sci U S A (2000) 1.02
Identification of two type IIa IgG-binding proteins expressed by a single group A streptococcus. J Immunol (1992) 1.02
Hyaluronic acid capsule: strategy for oxygen resistance in group A streptococci. J Bacteriol (1979) 1.02
M12 protein from Streptococcus pyogenes is a receptor for immunoglobulin G3 and human albumin. Infect Immun (1994) 1.02
CT angiography with volume rendering: advantages and applications in splanchnic vascular imaging. Radiology (1996) 1.00
The human antibody response to streptococcal C5a peptidase. J Infect Dis (1991) 1.00
Isolated DNA repeat region from fcrA76, the Fc-binding protein gene from an M-type 76 strain of group A streptococci, encodes a protein with Fc-binding activity. Mol Microbiol (1990) 0.99
Transcriptional control in the L-arabinose operon of Escherichia coli B-r. J Bacteriol (1974) 0.97
Enzymic reduction of d-biotin d-sulfoxide to d-biotin. Methods Enzymol (1979) 0.96
Retracted High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD. Infect Immun (1997) 0.96
Community-wide outbreak of group G streptococcal pharyngitis. Pediatrics (1991) 0.95
Insertional inactivation of virR in Streptococcus pyogenes M49 demonstrates that VirR functions as a positive regulator of streptococcal C5a peptidase and M protein in OF+ strains. Dev Biol Stand (1995) 0.94
CT angiography with volume rendering: imaging findings. AJR Am J Roentgenol (1995) 0.94
CT angiography with volume rendering for quantifying vascular stenoses: in vitro validation of accuracy. AJR Am J Roentgenol (1999) 0.93
More than one DNA sequence encodes the 2''-O-adenylyltransferase phenotype. Antimicrob Agents Chemother (1987) 0.92
Interactive three-dimensional volume rendering of spiral CT data: current applications in the thorax. Radiographics (1998) 0.92
Characterization of the streptococcal C5a peptidase using a C5a-green fluorescent protein fusion protein substrate. J Bacteriol (2000) 0.91
Differential expression of genes in the vir regulon of Streptococcus pyogenes is controlled by transcription termination. Mol Gen Genet (1996) 0.90
Abdominal image segmentation using three-dimensional deformable models. Invest Radiol (1998) 0.88
Intranasal bacteria induce Th1 but not Treg or Th2. Mucosal Immunol (2008) 0.87
Enzymatic reduction of D-biotin-d-sulfoxide with cell-free extracts of Escherichia coli. Biochem Biophys Res Commun (1974) 0.87
A restriction map and analysis of the terminal redundancy in the group a streptococcal bacteriophage SP24. Virology (1983) 0.87
Construction of recombination-deficient strains of Streptococcus gordonii by disruption of the recA gene. J Bacteriol (1993) 0.87
Genetic separation of serum opacity factor from M protein of group A streptococci. Infect Immun (1978) 0.86
Renal artery stenosis: CT angiography--comparison of real-time volume-rendering and maximum intensity projection algorithms. Radiology (1999) 0.85
Immunoglobulin-binding FcrA and Enn proteins and M proteins of group A streptococci evolved independently from a common ancestral protein. Med Microbiol Immunol (1994) 0.84
Streptococcus pyogenes type IIa IgG Fc receptor expression is co-ordinately regulated with M protein and streptococcal C5a peptidase. Mol Microbiol (1994) 0.84
CT angiography: thoracic vascular imaging with interactive volume rendering technique. J Comput Assist Tomogr (1997) 0.82
Virtual angioscopy using spiral CT and real-time interactive volume-rendering techniques. J Comput Assist Tomogr (1998) 0.81
Integration of bacteriophage SP24 into the chromosome of group A streptococci. J Bacteriol (1985) 0.81
Serological markers for hepatitis types A and B among United States Army blood donors. Mil Med (1981) 0.81
Three-dimensional CT: real-time interactive volume rendering. AJR Am J Roentgenol (1996) 0.79
Group A and group B streptococcal vaccine development. A round table presentation. Adv Exp Med Biol (1997) 0.79
High-frequency invasion of epithelial cells by Streptococcus pyogenes can be activated by fibrinogen and peptides containing the sequence RGD. Infect Immun (1998) 0.77